BioCentury
ARTICLE | Clinical News

Tesetaxel: Phase II started

May 14, 2012 7:00 AM UTC

Genta began the double-blind, placebo-controlled, international Phase II TESEGAST trial to compare 27 mg/m 2 oral tesetaxel on day 1 of a 21-day cycle in combination with Xeloda capecitabine vs. Xelo...